Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to see if Leukine(R) (sargramostim) improves the
effectiveness of the pneumococcal vaccine, a medicine used to prevent pneumococcal pneumonia,
in patients with chronic lymphocytic leukemia (CLL).